Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

INTRODUCTION: This work was undertaken to delineate intracellular signaling pathways for the PDE4 inhibitor apremilast and to examine interactions between apremilast, methotrexate and adenosine A(2A) receptors (A(2A)R). METHODS: After apremilast and LPS incubation, intracellular cAMP, TNF-α, IL-10,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Arthritis Res Ther
Huvudupphovsmän: Perez-Aso, Miguel, Montesinos, M. Carmen, Mediero, Aránzazu, Wilder, Tuere, Schafer, Peter H., Cronstein, Bruce
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570588/
https://ncbi.nlm.nih.gov/pubmed/26370839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0771-6
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk